# Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

> **NCT01181479** · PHASE3 · COMPLETED · sponsor: **Agile Therapeutics** · enrollment: 1504 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** AG200-15 (cycles 1-13)
- **DRUG:** Lessina crossover to AG200-15

## Key facts

- **NCT ID:** NCT01181479
- **Lead sponsor:** Agile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-12
- **Final completion:** 2012-03
- **Target enrollment:** 1504 (ACTUAL)
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181479, "Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*